To demonstrate the interaction between glioma tumor cells and immune cells, Zhai et al. showed that mRNA expression of Indoleamine 2,3-dioxygense 1 (IDO1), an immunossupressive enzyme, increases in tumor cells with histologic grade in gliomas. Here, IDO1 is linked to central nervous system cancer.